1. Home
  2. ALLO vs WSR Comparison

ALLO vs WSR Comparison

Compare ALLO & WSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • WSR
  • Stock Information
  • Founded
  • ALLO 2017
  • WSR 1998
  • Country
  • ALLO United States
  • WSR United States
  • Employees
  • ALLO N/A
  • WSR N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • WSR Real Estate Investment Trusts
  • Sector
  • ALLO Health Care
  • WSR Real Estate
  • Exchange
  • ALLO Nasdaq
  • WSR Nasdaq
  • Market Cap
  • ALLO 677.5M
  • WSR 739.7M
  • IPO Year
  • ALLO 2018
  • WSR 2010
  • Fundamental
  • Price
  • ALLO $2.27
  • WSR $14.33
  • Analyst Decision
  • ALLO Buy
  • WSR Strong Buy
  • Analyst Count
  • ALLO 12
  • WSR 3
  • Target Price
  • ALLO $10.06
  • WSR $15.00
  • AVG Volume (30 Days)
  • ALLO 2.6M
  • WSR 245.9K
  • Earning Date
  • ALLO 11-07-2024
  • WSR 10-30-2024
  • Dividend Yield
  • ALLO N/A
  • WSR 3.45%
  • EPS Growth
  • ALLO N/A
  • WSR N/A
  • EPS
  • ALLO N/A
  • WSR 0.41
  • Revenue
  • ALLO $43,000.00
  • WSR $149,446,000.00
  • Revenue This Year
  • ALLO N/A
  • WSR N/A
  • Revenue Next Year
  • ALLO $5,902.96
  • WSR $4.35
  • P/E Ratio
  • ALLO N/A
  • WSR $34.91
  • Revenue Growth
  • ALLO 26.47
  • WSR 4.67
  • 52 Week Low
  • ALLO $2.01
  • WSR $10.77
  • 52 Week High
  • ALLO $5.78
  • WSR $14.80
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 36.00
  • WSR 54.38
  • Support Level
  • ALLO $2.95
  • WSR $13.55
  • Resistance Level
  • ALLO $3.36
  • WSR $14.80
  • Average True Range (ATR)
  • ALLO 0.26
  • WSR 0.31
  • MACD
  • ALLO -0.06
  • WSR -0.00
  • Stochastic Oscillator
  • ALLO 0.91
  • WSR 62.00

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. Its property portfolio includes retail and office/flex properties. The company's properties are located in business-friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The organization derives revenue in the form of rental revenues.

Share on Social Networks: